Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.26.3
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2024 $ 0 $ 0 $ 166,357,208 $ (166,316,447) $ 40,761
Beginning balance, shares at Dec. 31, 2024 78,859        
Beginning balance, shares at Dec. 31, 2024   0      
Issuance of common stock for exercises of pre-funded warrants $ 2 $ 0 (2) 0 0
Issuance of common stock for exercises of pre-funded warrants, shares 176,116        
Issuance of common stock from the At the Market offering, net of issuance costs of $53,525 $ 3 8,846,758 8,846,761
Issuance of common stock from the At the Market offering, net of issuance costs, shares 220,515        
Issuance of common stock and pre-funded warrants, net of issuance costs of $21,136,401 $ 1 10,703,881 10,703,882
Issuance of common stock and pre-funded warrants, net of issuance cost, shares 53,750        
Repurchases of common stock for treasury stock $ (401,806) (401,806)
Repurchases of common stock for treasury stock, shares (47,886) 47,886      
Stock-based compensation 10,052 10,052
Net loss (2,460,430) (2,460,430)
Ending balance, value at Mar. 31, 2025 $ 6 $ (401,806) 185,917,897 (168,776,877) 16,739,220
Ending balance, shares at Mar. 31, 2025 481,354        
Ending balance, shares at Mar. 31, 2025   47,886      
Beginning balance, value at Dec. 31, 2024 $ 0 $ 0 166,357,208 (166,316,447) 40,761
Beginning balance, shares at Dec. 31, 2024 78,859        
Beginning balance, shares at Dec. 31, 2024   0      
Purchase fractional shares         (941)
Net loss         (35,531,655)
Ending balance, value at Sep. 30, 2025 $ 475 $ (39,406,458) 678,894,847 (201,848,102) 437,640,762
Ending balance, shares at Sep. 30, 2025 42,337,879        
Ending balance, shares at Sep. 30, 2025   5,234,166      
Beginning balance, value at Mar. 31, 2025 $ 6 $ (401,806) 185,917,897 (168,776,877) 16,739,220
Beginning balance, shares at Mar. 31, 2025 481,354        
Beginning balance, shares at Mar. 31, 2025   47,886      
Issuance of common stock for exercises of pre-funded warrants $ 0 $ 0 0 0 0
Issuance of common stock for exercises of pre-funded warrants, shares 50,001        
Issuance of common stock for disputed shares from November 2024 reverse stock split (see Note 2) $ 0 0 0 0 0
Issuance of common stock for disputed shares from November 2024 reverse stock split, shares 23,617        
Purchase fractional shares (941) (941)
Purchase fractional shares, shares (179)        
Exchange of common stock for pre-funded warrants $ 0 0 0 0 0
Exchange of common stock for pre-funded warrants, shares (4,323)        
Repurchases of common stock for treasury stock $ (109,101) (109,101)
Repurchases of common stock for treasury stock, shares (17,462) 17,462      
Stock-based compensation 1,090,618 1,090,618
Net loss (3,899,897) (3,899,897)
Ending balance, value at Jun. 30, 2025 $ 6 $ (510,907) 187,007,574 (172,676,774) 13,819,899
Ending balance, shares at Jun. 30, 2025 533,008        
Ending balance, shares at Jun. 30, 2025   65,348      
Issuance of common stock for exercises of pre-funded warrants $ 23 $ 0 (23) 0 0
Issuance of common stock for exercises of pre-funded warrants, shares 2,311,947        
Issuance of common stock from the At the Market offering, net of issuance costs of $53,525 $ 1 1,441,300 1,441,301
Issuance of common stock from the At the Market offering, net of issuance costs, shares 136,053        
Issuance of common stock and pre-funded warrants, net of issuance costs of $21,136,401 $ 444 474,907,637 474,908,081
Issuance of common stock and pre-funded warrants, net of issuance cost, shares 44,414,189        
Repurchases of common stock for treasury stock $ (38,895,551) (38,895,551)
Repurchases of common stock for treasury stock, shares (5,168,818) 5,168,818      
Stock-based compensation 13,754,360 13,754,360
Net loss (29,171,328) (29,171,328)
Issuance of common stock for exercises of warrants $ 1 1,783,999 1,784,000
Issuance of common stock for exercises of warrants, shares 111,500        
Ending balance, value at Sep. 30, 2025 $ 475 $ (39,406,458) 678,894,847 (201,848,102) 437,640,762
Ending balance, shares at Sep. 30, 2025 42,337,879        
Ending balance, shares at Sep. 30, 2025   5,234,166      
Beginning balance, value at Dec. 31, 2025 $ 475 $ (96,282,082) 681,864,757 (316,368,933) $ 269,214,217
Beginning balance, shares at Dec. 31, 2025 33,800,951        
Beginning balance, shares at Dec. 31, 2025   13,771,094     13,771,094
Issuance of common stock for exercises of pre-funded warrants $ 34 (3) $ 31
Issuance of common stock for exercises of pre-funded warrants, shares 3,396,940        
Issuance of common stock and pre-funded warrants, net of issuance costs of $21,136,401 $ 26 24,787,653 24,787,679
Issuance of common stock and pre-funded warrants, net of issuance cost, shares 2,558,422        
Repurchases of common stock for treasury stock $ (44,219,787) (44,219,787)
Repurchases of common stock for treasury stock, shares (10,429,663) 10,429,663      
Stock-based compensation 1,704,252 1,704,252
Net loss (85,403,548) (85,403,548)
Ending balance, value at Mar. 31, 2026 $ 535 $ (140,501,869) 708,356,659 (401,772,481) 166,082,844
Ending balance, shares at Mar. 31, 2026 29,326,650        
Ending balance, shares at Mar. 31, 2026   24,200,757      
Beginning balance, value at Dec. 31, 2025 $ 475 $ (96,282,082) 681,864,757 (316,368,933) $ 269,214,217
Beginning balance, shares at Dec. 31, 2025 33,800,951        
Beginning balance, shares at Dec. 31, 2025   13,771,094     13,771,094
Net loss         $ (104,451,888)
Ending balance, value at Sep. 30, 2026 $ 544 $ (150,252,502) 708,449,452 (420,820,821) $ 137,376,673
Ending balance, shares at Sep. 30, 2026 28,160,111        
Ending balance, shares at Sep. 30, 2026   26,310,005     26,310,005
Beginning balance, value at Mar. 31, 2026 $ 535 $ (140,501,869) 708,356,659 (401,772,481) $ 166,082,844
Beginning balance, shares at Mar. 31, 2026 29,326,650        
Beginning balance, shares at Mar. 31, 2026   24,200,757      
Issuance of common stock for exercises of pre-funded warrants $ 9 9
Issuance of common stock for exercises of pre-funded warrants, shares 892,709        
Repurchases of common stock for treasury stock $ (9,750,633) (9,750,633)
Repurchases of common stock for treasury stock, shares (2,109,248) 2,109,248      
Stock-based compensation 92,789 92,789
Net loss (43,034,434) (43,034,434)
Ending balance, value at Jun. 30, 2026 $ 544 $ (150,252,502) 708,449,448 (444,806,915) 113,390,575
Ending balance, shares at Jun. 30, 2026 28,110,111        
Ending balance, shares at Jun. 30, 2026   26,310,005      
Issuance of common stock for exercises of pre-funded warrants 4 4
Issuance of common stock for exercises of pre-funded warrants, shares 50,000        
Net loss 23,986,094 23,986,094
Ending balance, value at Sep. 30, 2026 $ 544 $ (150,252,502) $ 708,449,452 $ (420,820,821) $ 137,376,673
Ending balance, shares at Sep. 30, 2026 28,160,111        
Ending balance, shares at Sep. 30, 2026   26,310,005     26,310,005